ANAHEIM, Calif. & CAMBRIDGE, Mass.--(BUSINESS WIRE)--T2 Biosystems, Inc., a company developing the first portable medical diagnostic products that combine nanotechnology and miniaturized magnetic resonance (MR) technology, today announced the company’s authorship of a chapter in the new book Point-of-Care Testing: Needs, Opportunity, and Innovation, 3rd Edition. This book will be released during American Association of Clinical Chemistry (AACC) annual meeting, being held this week in Anaheim, CA.
